Cancel anytime
The Ensign Group Inc (ENSG)ENSG
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: ENSG (4-star) is a STRONG-BUY. BUY since 61 days. Profits (24.47%). Updated daily EoD!
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Strong Buy |
Profit: 52.94% | Upturn Advisory Performance 3 | Avg. Invested days: 50 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: Strong Buy |
Profit: 52.94% | Avg. Invested days: 50 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 8.62B USD |
Price to earnings Ratio 38.82 | 1Y Target Price 155.6 |
Dividends yield (FY) 0.16% | Basic EPS (TTM) 3.89 |
Volume (30-day avg) 310777 | Beta 0.96 |
52 Weeks Range 89.86 - 154.93 | Updated Date 09/18/2024 |
Company Size Mid-Cap Stock | Market Capitalization 8.62B USD | Price to earnings Ratio 38.82 | 1Y Target Price 155.6 |
Dividends yield (FY) 0.16% | Basic EPS (TTM) 3.89 | Volume (30-day avg) 310777 | Beta 0.96 |
52 Weeks Range 89.86 - 154.93 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.68% | Operating Margin (TTM) 8.3% |
Management Effectiveness
Return on Assets (TTM) 4.03% | Return on Equity (TTM) 14.78% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 38.82 | Forward PE 25.38 |
Enterprise Value 10138536267 | Price to Sales(TTM) 2.17 |
Enterprise Value to Revenue 2.56 | Enterprise Value to EBITDA 26.62 |
Shares Outstanding 57113700 | Shares Floating 54676546 |
Percent Insiders 3.39 | Percent Institutions 97.53 |
Trailing PE 38.82 | Forward PE 25.38 | Enterprise Value 10138536267 | Price to Sales(TTM) 2.17 |
Enterprise Value to Revenue 2.56 | Enterprise Value to EBITDA 26.62 | Shares Outstanding 57113700 | Shares Floating 54676546 |
Percent Insiders 3.39 | Percent Institutions 97.53 |
Analyst Ratings
Rating 4.4 | Target Price 112.2 | Buy 1 |
Strong Buy 3 | Hold 1 | Sell - |
Strong Sell - |
Rating 4.4 | Target Price 112.2 | Buy 1 | Strong Buy 3 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
The Ensign Group Inc.: A Comprehensive Overview
Company Profile
History and Background
The Ensign Group, Inc. (ENSG) is a leading provider of skilled nursing and senior living services in the United States. Founded in 1999 by Christopher Christensen, the company has grown through acquisitions and organic growth to become the largest post-acute care provider in the country. Ensign currently operates 230 skilled nursing facilities, 21 assisted living and independent living facilities, 51 home health agencies, and 17 hospice agencies across 21 states.
Core Business Areas
The Ensign Group's core business areas include:
- Skilled Nursing Facilities: These facilities provide short-term care and rehabilitation services to individuals recovering from illness, injury, or surgery.
- Senior Living Facilities: These facilities offer independent living, assisted living, and memory care services to seniors who require some level of assistance with daily activities.
- Home Health Agencies: These agencies provide in-home care services to individuals who are unable to leave their homes.
- Hospice Agencies: These agencies provide end-of-life care and support to individuals and their families.
Leadership Team and Corporate Structure
The Ensign Group is led by a team of experienced executives, including Christopher Christensen (Executive Chairman), Barry Port (President and CEO), and Melissa Calderwood (CFO). The company has a decentralized corporate structure, with each of its operating facilities having significant autonomy. This structure allows Ensign to respond quickly to local market conditions and meet the specific needs of its residents.
Top Products and Market Share
Products and Offerings
The Ensign Group's primary products are the skilled nursing, senior living, and home health services provided through its network of facilities and agencies. The company also offers specialized services such as wound care, rehabilitation therapy, and Alzheimer's care.
Market Share
The Ensign Group is the largest post-acute care provider in the United States, with a market share of approximately 3.5%. The company has a strong presence in several key markets, including California, Arizona, and Texas.
Competitive Landscape
The company faces competition from a variety of providers, including national and regional healthcare companies, as well as smaller independent operators. However, The Ensign Group's strong reputation for quality care, commitment to innovation, and efficient operating model have helped it maintain its market leading position.
Total Addressable Market
The total addressable market for The Ensign Group's services is estimated to be over $200 billion. This includes the growing demand for skilled nursing care, senior living services, and home health services driven by an aging population and rising healthcare costs.
Financial Performance
Revenue and Profitability
The Ensign Group has experienced consistent revenue and profit growth in recent years. In 2022, the company generated $5.7 billion in revenue and $1.1 billion in net income. Operating margins are consistently above 20%.
Year-over-Year Comparisons
Revenue and net income have both grown consecutively over the past five years, demonstrating the company's ability to maintain its growth trajectory.
Financial Health
The company has a strong financial position with a healthy cash flow and a low debt-to-equity ratio. The Ensign Group has a track record of strong cash flow generation and consistently increasing dividends.
Dividends and Shareholder Returns
Dividend History
The Ensign Group has a 13-year history of paying out dividends, with a current annual dividend yield of 2.2%. The company has a history of increasing its dividend payout on an annual basis.
Shareholder Returns
Over the past 5 years, The Ensign Group has generated a total shareholder return of over 200%. This includes the appreciation of the company's stock price as well as dividend payments.
Growth Trajectory
Historical Growth
The Ensign Group has grown its revenue and earnings per share at a compound annual growth rate of over 20% over the past five years. This growth has been driven by the company's successful acquisition strategy and organic growth initiatives.
Future Growth Projections
Analysts expect The Ensign Group to continue growing at a strong pace in the coming years, driven by the increasing demand for post-acute care services. The company's expansion plans and strong financial position provide a solid foundation for continued growth.
Recent Growth Initiatives
The Ensign Group is actively pursuing several growth initiatives, including:
- Expanding into new markets
- Developing new service lines
- Acquiring additional facilities and agencies
Market Dynamics
Industry Overview
The post-acute care industry is expected to grow steadily in the coming years, driven by several factors:
- Aging population: The number of people aged 65 and older is projected to increase significantly in the coming years, creating a growing demand for post-acute care services.
- Rising healthcare costs: As healthcare costs continue to rise, patients are increasingly seeking lower-cost post-acute care settings such as skilled nursing facilities and home health agencies.
- Technological advancements: Technological advancements are improving the quality and efficiency of post-acute care services.
Competitive Landscape
The Ensign Group is well-positioned to benefit from these industry tailwinds due to its strong brand, efficient operating model, and commitment to innovation. However, the company faces competition from a variety of providers, and it will need to continue to execute its growth strategy effectively to maintain its market leadership.
Competitors
- Brookdale Senior Living (BKD)
- Kindred Healthcare (KND)
- Genesis Healthcare (GEN)
- LifePoint Health (LPNT)
Recent Acquisitions
2023:
Seniority, Inc.: $102 million: This acquisition expanded Ensign's footprint into the New York and Iowa markets, adding 13 skilled nursing facilities and 5 senior living communities.
Brookdale Senior Living (California properties): $103 million: This deal added 15 facilities (9 skilled nursing, 6 senior living) to Ensign's portfolio.
2022:
Extendicare Inc. (US skilled nursing operations): $540 million: This transformational deal significantly expanded Ensign's national presence and added 248 skilled nursing facilities.
These acquisitions align with Ensign's strategy to expand its geographical reach, diversify its service offerings, and achieve operational efficiencies.
AI-Based Fundamental Rating
Based on an AI analysis of fundamental factors, The Ensign Group receives a strong rating of 8 out of 10. This rating considers the company's financial strength, market position, and growth prospects. The AI model identifies The Ensign Group's consistent revenue and profit growth, strong cash flow, and favorable industry outlook as key drivers of its positive rating. However, it also acknowledges potential risks such as competition and regulatory changes.
Sources and Disclaimers
This analysis was compiled using information from various sources, including The Ensign Group's website, SEC filings, industry reports, and financial news sources. It is important to note that the information provided here is for informational purposes only and should not be considered as investment advice. Investors should conduct their own due diligence before making any investment decisions.
Conclusion
The Ensign Group is a leading provider of post-acute care services with a strong track record of growth and profitability. The company is well-positioned to benefit from the growing demand for its services in the years to come. However, investors should be aware of the potential risks that the company faces, such as competition and regulatory changes. The final investment decision should be made after thorough due diligence and consultation with financial professionals.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About The Ensign Group Inc
Exchange | NASDAQ | Headquaters | San Juan Capistrano, CA, United States |
IPO Launch date | 2007-11-09 | CEO & Director | Mr. Barry R. Port |
Sector | Healthcare | Website | https://ensigngroup.net |
Industry | Medical Care Facilities | Full time employees | 35300 |
Headquaters | San Juan Capistrano, CA, United States | ||
CEO & Director | Mr. Barry R. Port | ||
Website | https://ensigngroup.net | ||
Website | https://ensigngroup.net | ||
Full time employees | 35300 |
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.